Search Results - Hitoshi Toyoda
- Showing 1 - 6 results of 6
-
1
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor by Kazuyuki Hamada, Kazuyuki Hamada, Junya Isobe, Kouya Hattori, Kouya Hattori, Masahiro Hosonuma, Masahiro Hosonuma, Masahiro Hosonuma, Masahiro Hosonuma, Yuta Baba, Masakazu Murayama, Masakazu Murayama, Masakazu Murayama, Masakazu Murayama, Yoichiro Narikawa, Yoichiro Narikawa, Yoichiro Narikawa, Yoichiro Narikawa, Hitoshi Toyoda, Hitoshi Toyoda, Hitoshi Toyoda, Hitoshi Toyoda, Eiji Funayama, Kohei Tajima, Kohei Tajima, Midori Shida, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Ryotaro Ohkuma, Yutaro Kubota, Takehiko Sambe, Mayumi Tsuji, Mayumi Tsuji, Satoshi Wada, Yuji Kiuchi, Yuji Kiuchi, Shinichi Kobayashi, Atsuo Kuramasu, Atsushi Horiike, Yun-Gi Kim, Takuya Tsunoda, Kiyoshi Yoshimura, Kiyoshi Yoshimura
Published in Frontiers in Immunology (2023-05-01)Get full text
Article -
2
Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors by Yuya Hirasawa, Junya Isobe, Masahiro Hosonuma, Masahiro Hosonuma, Masahiro Hosonuma, Masahiro Hosonuma, Toshiaki Tsurui, Toshiaki Tsurui, Toshiaki Tsurui, Yuta Baba, Yuta Baba, Eiji Funayama, Eiji Funayama, Eiji Funayama, Kohei Tajima, Kohei Tajima, Masakazu Murayama, Masakazu Murayama, Masakazu Murayama, Yoichiro Narikawa, Yoichiro Narikawa, Yoichiro Narikawa, Hitoshi Toyoda, Hitoshi Toyoda, Hitoshi Toyoda, Hitoshi Toyoda, Midori Shida, Aya Sasaki, Aya Sasaki, Yuuki Maruyama, Yuuki Maruyama, Yuuki Maruyama, Yasunobu Amari, Yasunobu Amari, Yasunobu Amari, Yasunobu Amari, Emiko Mura, Risako Suzuki, Nana Iriguchi, Tomoyuki Ishiguro, Ryotaro Ohkuma, Masahiro Shimokawa, Hirotsugu Ariizumi, Yutaro Kubota, Atsushi Horiike, Takehiko Sambe, Naoki Uchida, Satoshi Wada, Satoshi Wada, Shinichi Kobayashi, Yuji Kiuchi, Yuji Kiuchi, Atsuo Kuramasu, Kiyoshi Yoshimura, Kiyoshi Yoshimura, Takuya Tsunoda
Published in Frontiers in Immunology (2025-05-01)Get full text
Article -
3
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit by Toshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, Yuuki Maruyama, Yasunobu Amari, Eiji Funayama, Kohei Tajima, Hitoshi Toyoda, Junya Isobe, Yoshitaka Yamazaki, Yuta Baba, Midori Shida, Yuko Udaka, Emiko Mura, Risako Suzuki, Nana Iriguchi, Tomoyuki Ishiguro, Yuya Hirasawa, Ryotaro Ohkuma, Masahiro Shimokawa, Hirotsugu Ariizumi, Yutaro Kubota, Atsushi Horiike, Satoshi Wada, Atsuo Kuramasu, Mayumi Tsuji, Yuji Kiuchi, Takuya Tsunoda, Kiyoshi Yoshimura
Published in Discover Oncology (2025-03-01)Get full text
Article -
4
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells by Hitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, Masakazu Murayama, Yoichiro Narikawa, Junya Isobe, Yuta Baba, Kohei Tajima, Eiji Funayama, Midori Shida, Yuki Maruyama, Aya Sasaki, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Sei Kobayashi, Atsushi Horiike, Noriko Hida, Takehiko Sambe, Koji Nobe, Satoshi Wada, Hitome Kobayashi, Mayumi Tsuji, Shinichi Kobayashi, Takuya Tsunoda, Yoshifumi Kudo, Yuji Kiuchi, Kiyoshi Yoshimura
Published in Scientific Reports (2024-10-01)Get full text
Article -
5
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody by Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, Sei Kobayashi, Akiko Sasaki, Yuta Baba, Yoichiro Narikawa, Hitoshi Toyoda, Junya Isobe, Eiji Funayama, Kohei Tajima, Aya Sasaki, Yuki Maruyama, Yoshitaka Yamazaki, Midori Shida, Kazuyuki Hamada, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Ryotaro Ohkuma, Yutaro Kubota, Atsushi Horiike, Takehiko Sambe, Mayumi Tsuji, Satoshi Wada, Shinichi Kobayashi, Toshikazu Shimane, Takuya Tsunoda, Hitome Kobayashi, Yuji Kiuchi, Kiyoshi Yoshimura
Published in Scientific Reports (2024-05-01)Get full text
Article -
6
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity by Yoichiro Narikawa, Atsuo Kuramasu, Masahiro Hosonuma, Masakazu Murayama, Eiji Funayama, Akiko Sasaki, Yuta Baba, Hitoshi Toyoda, Junya Isobe, Kohei Tajima, Rie Nakashima, Aya Sasaki, Yuki Maruyama, Yoshitaka Yamazaki, Midori Shida, Toshiaki Tsurui, Yuya Hirasawa, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Ryotaro Ohkuma, Yutaro Kubota, Takehiko Sambe, Mayumi Tsuji, Satoshi Wada, Atsushi Horiike, Shinichi Kobayashi, Takuya Tsunoda, Sei Kobayashi, Hitome Kobayashi, Tatsunori Oguchi, Toshikazu Shimane, Yuji Kiuchi, Kiyoshi Yoshimura
Published in Cancer Immunology, Immunotherapy (2025-08-01)Get full text
Article
